Targeting intrinsically-resistant breast cancer stem cells with gamma-secretase inhibitors

Short term biological effects of the combination of letrozole and zoledronic acid on invasive breast cancer

Denosumab versus zoledronic acid for skeletal-related events in breast cancer patients with bone metastases

Use of bisphosphonates and risk of postmenopausal breast cancer

Oral bisphosphonate and breast cancer: prospective results from the Women's Health Initiative (WHI)

Translation of endocrine systemic treatment

Using biology of tumours to predict effective therapies

Optimal way to use herceptin with adjuvant therapy

Cancer and the bone micro-environment

Emerging approaches to clinical trial design

Evaluating strategies for endocrine therapy

How life style factors effect survival of breast cancer patients